Interestingly, overexpression of cdc25A is indicative of a weakly increased risk of dying of disease (Cangi et al, 2000), whereas cyclin A is a significant prognostic indicator of poor prognosis, for OR-positive as well as for OR-negative breast cancer (Bukholm et al, 2001; this study). Here, CCNA2 is linked to breast cancer.